Free Trial

Sanofi (SNY) SEC Filings & 10K Form

Sanofi logo
$48.18 -0.14 (-0.29%)
Closing price 04:00 PM Eastern
Extended Trading
$48.55 +0.37 (+0.77%)
As of 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sanofi SEC Filings

DateFilerForm TypeView
07/02/2025
7:25 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2025
3:49 PM
Sanofi (Filer)
Sanofi (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/24/2025
7:31 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2025
5:43 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
7:33 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
5:07 AM
Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-T
06/06/2025
10:35 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:11 PM
Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:09 AM
Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC TO-C
06/02/2025
5:07 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2025
9:51 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2025
7:09 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2025
9:55 AM
Sanofi (Filer)
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
05/12/2025
3:50 PM
Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
05/06/2025
5:15 AM
Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
05/05/2025
12:12 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2025
1:50 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2025
5:48 PM
Innate Pharma SA (Subject)
Innate Pharma SA (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SCHEDULE 13G/A
04/24/2025
9:13 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2025
6:39 PM
BlackRock, Inc. (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
04/22/2025
11:29 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
8:18 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
5:11 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2025
7:43 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2025
5:15 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
12:39 PM
Sanofi (Filer)
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2025
10:56 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2025
5:04 AM
Sanofi (Filer)
Sanofi (Filer)
Form S-8 POS
03/20/2025
10:06 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
11:23 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
9:24 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2025
5:14 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2025
11:18 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
11:14 AM
Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:28 AM
Sanofi (Filer)
Sanofi (Filer)
Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers
02/13/2025
1:11 PM
Sanofi (Filer)
Sanofi (Filer)
Form IRANNOTICE
02/13/2025
12:41 PM
Sanofi (Filer)
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/13/2025
11:23 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2025
10:14 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
11:14 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
8:50 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.

This little-known company holds nearly 100 patents and trades for around $7
01/24/2025
5:04 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
7:40 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
1:08 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2024
5:07 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
10:07 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
11:23 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
1:49 PM
Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
Form SC 13G/A
11/07/2024
10:35 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
5:56 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
11:39 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
10:47 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
2:35 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
10:06 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
1:51 PM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
11:46 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
9:46 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
8:06 AM
MeiraGTx Holdings plc (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
Form SC 13G/A
08/13/2024
5:30 AM
MeiraGTx Holdings plc (Issuer)
Sanofi (Reporting)
Sanofi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
5:05 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
10:43 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
9:26 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2024
10:28 AM
Sanofi (Filer)
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SNY) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners